These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27044414)

  • 1. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.
    Bonilla C; Lewis SJ; Martin RM; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Lathrop M; Davey Smith G;
    BMC Med; 2016 Apr; 14():66. PubMed ID: 27044414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
    Bonilla C; Lewis SJ; Rowlands MA; Gaunt TR; Davey Smith G; Gunnell D; Palmer T; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Grönberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Martin RM; Holly JM
    Int J Cancer; 2016 Oct; 139(7):1520-33. PubMed ID: 27225428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood lipids and prostate cancer: a Mendelian randomization analysis.
    Bull CJ; Bonilla C; Holly JM; Perks CM; Davies N; Haycock P; Yu OH; Richards JB; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; MacInnis RJ; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Micheal A; Pandha H; Smith GD; Lewis SJ; Martin RM;
    Cancer Med; 2016 Jun; 5(6):1125-36. PubMed ID: 26992435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.
    Davies NM; Gaunt TR; Lewis SJ; Holly J; Donovan JL; Hamdy FC; Kemp JP; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Smith GD; Martin RM
    Cancer Causes Control; 2015 Nov; 26(11):1603-16. PubMed ID: 26387087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mendelian randomization does not support serum calcium in prostate cancer risk.
    Yarmolinsky J; Berryman K; Langdon R; Bonilla C; ; Davey Smith G; Martin RM; Lewis SJ
    Cancer Causes Control; 2018 Nov; 29(11):1073-1080. PubMed ID: 30306355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
    Au Yeung SL; Schooling CM
    BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.
    Taylor AE; Martin RM; Geybels MS; Stanford JL; Shui I; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Blot W; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Donovan J; Munafò MR
    Int J Cancer; 2017 Jan; 140(2):322-328. PubMed ID: 27741566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voice break in boys-temporal relations with other pubertal milestones and likely causal effects of BMI.
    Busch AS; Hollis B; Day FR; Sørensen K; Aksglaede L; Perry JRB; Ong KK; Juul A; Hagen CP
    Hum Reprod; 2019 Aug; 34(8):1514-1522. PubMed ID: 31348498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pubertal maturation and risk of childhood asthma: A Mendelian randomization and longitudinal study.
    Chen YC; Fan HY; Yang C; Lee YL
    Allergy; 2020 Apr; 75(4):892-900. PubMed ID: 31386217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey.
    Worley G; Houlihan CM; Herman-Giddens ME; O'Donnell ME; Conaway M; Stallings VA; Chumlea WC; Henderson RC; Fung EB; Rosenbaum PL; Samson-Fang L; Liptak GS; Calvert RE; Stevenson RD
    Pediatrics; 2002 Nov; 110(5):897-902. PubMed ID: 12415027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age of puberty and Sleep duration: Observational and Mendelian randomization study.
    Wang J; Kwok MK; Au Yeung SL; Zhao J; Li AM; Lam HS; Leung GM; Schooling CM
    Sci Rep; 2020 Feb; 10(1):3202. PubMed ID: 32081851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.
    Kazmi N; Valeeva EV; Khasanova GR; Lewis SJ; Plotnikov D;
    Cancer Causes Control; 2023 Aug; 34(8):725-734. PubMed ID: 37178364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Pubertal Development and Midlife Blood Pressure in Men and Women: A Mendelian Randomization Study.
    Chan II; Kwok MK; Schooling CM
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e386-e393. PubMed ID: 34343299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
    Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
    Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between schizophrenia and prostate cancer risk: Results from a pool of cohort studies and Mendelian randomization analysis.
    Ge F; Huo Z; Liu Y; Du X; Wang R; Lin W; Wang R; Chen J; Lu Y; Wen Y; Cao H; Shang S; Eftekhar M; Gu D
    Compr Psychiatry; 2022 May; 115():152308. PubMed ID: 35303584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controls.
    Kazmi N; Haycock P; Tsilidis K; Lynch BM; Truong T; ; Martin RM; Lewis SJ
    Int J Epidemiol; 2020 Apr; 49(2):587-596. PubMed ID: 31802111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone-binding globulin on prostate cancer.
    Wan B; Lu L; Lv C
    Andrology; 2023 Sep; 11(6):1023-1030. PubMed ID: 36524281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
    Desai TA; Hedman ÅK; Dimitriou M; Koprulu M; Figiel S; Yin W; Johansson M; Watts EL; Atkins JR; Sokolov AV; Schiöth HB; Gunter MJ; Tsilidis KK; Martin RM; Pietzner M; Langenberg C; Mills IG; Lamb AD; Mälarstig A; Key TJ; ; Travis RC; Smith-Byrne K
    EBioMedicine; 2024 Jul; 105():105168. PubMed ID: 38878676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically proxied morning chronotype was associated with a reduced risk of prostate cancer.
    Sun X; Ye D; Jiang M; Qian Y; Mao Y
    Sleep; 2021 Oct; 44(10):. PubMed ID: 33878190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
    Yarmolinsky J; Bonilla C; Haycock PC; Langdon RJQ; Lotta LA; Langenberg C; Relton CL; Lewis SJ; Evans DM; ; Davey Smith G; Martin RM
    J Natl Cancer Inst; 2018 Sep; 110(9):1035-1038. PubMed ID: 29788239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.